Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia

January 17, 2012 By AxoGen, Inc.

SAN ANTONIO–(BUSINESS
WIRE
)–The results of a study conducted by Vidacare Corporation comparing
whether Intraosseous (IO) vascular access may be used to infuse chilled saline
as effectively as peripheral intravenous (IV) access to achieve therapeutic
hypothermia found no statistical difference between the two routes. The
findings were announced on January 12 at an oral presentation at the National
Association of EMS Physicians® 2012 Annual Meeting by Dr. Larry J. Miller and
the Science and Clinical team from Vidacare Corporation, makers of the EZ-IO®
Intraosseous Infusion System.

The study [Abstract #2], “Infusing Chilled Saline Through
the Intraosseous Route is Equivalent to Infusion Through the Intravenous Route
in Reducing the Core Temperature in Swine,” investigated whether Intraosseous
(IO) vascular access may be effectively used to infuse chilled saline to
achieve therapeutic hypothermia (TH) as an alternative to peripheral
intravenous (IV) access. The study found that IO and IV temperature reductions
were statistically equivalent and concluded no clinical or statistical
difference between IV and IO when comparing the two routes for infusion of
chilled saline for therapeutic hypothermia.

The research study used the EZ-IO® Intraosseous Infusion
System – the first battery-powered device to establish immediate vascular
access and the only IO device which is FDA cleared for humeral insertion. The
EZ-IO is used by 90 percent of US advanced life support ambulances and over
half of US Emergency Departments, as well as the US Military.

Established in 2001, Vidacare Corporation is the developer
of a broad technology platform that is defining the field of intraosseous
medicine. Current products include the EZ-IO® Intraosseous Infusion System, the OnControl™ Bone Marrow System and the OnControl™ Bone Access System, and applications include
vascular access, emergency and disaster medicine, oncology and spinal surgery.
Vidacares focus on enhancing clinical efficacy, patient safety and comfort,
and reducing complications and their associated costs, has resulted in its
devices becoming the recognized technology standard. Privately held, the
company is based in San Antonio,
Texas, and its products are
marketed in over 50 countries worldwide. www.vidacare.com

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech